Roberto J. Bernardo, MD, MS, ATSF 🇵🇪🇺🇸 (@rjbernardomd) 's Twitter Profile
Roberto J. Bernardo, MD, MS, ATSF 🇵🇪🇺🇸

@rjbernardomd

I specialize in pulmonary vascular disease. My goal is to understand PH phenotypes in underserved populations | #AllAboutTheRV | Also, #CandyCrush expert

ID: 1259255502384492544

calendar_today09-05-2020 22:54:59

1,1K Tweet

921 Takipçi

321 Takip Edilen

The Pulmonary Vascular Research Institute (@pvri) 's Twitter Profile Photo

Let the debate begin!💥 At #DDDS2025 in Amsterdam, we’re diving into disease modification – featuring a pro/con debate with Dr Mardi Gomberg and Roham Zamanian. ⚡ Pro/con debate: Drug development in the post vasodilator era - including a demonstration of disease modification Expect a

Let the debate begin!💥
At #DDDS2025 in Amsterdam, we’re diving into disease modification – featuring a pro/con debate with <a href="/mardigomberg/">Dr Mardi Gomberg</a> and <a href="/docroham/">Roham Zamanian</a>.

⚡ Pro/con debate: Drug development in the post vasodilator era - including a demonstration of disease modification

Expect a
Maryam S. Sanjani, PhD 🫁🫀 (@maryamsanjani) 's Twitter Profile Photo

Please join the latest discussions: “3D Imaging Reveals Complex Microvascular Remodeling in the Right Ventricle in Pulmonary Hypertension” Date/Time: Tues, June. 3, 2025, 12 p.m. eastern Registration Link: thoracic.zoom.us/meeting/regist… Presenter: Edda Spiekerkoetter, MD

ATS PC Assembly (@ats_pc) 's Twitter Profile Photo

This #ATS2025 post-graduate course has an amazing line-up of talks and breakout sessions with experts: "Pulmonary Hypertension - What You Need to Know Today" 🗓️May 16 ✅Register here: ats2025.d365.events/directory/sess…

Roberto J. Bernardo, MD, MS, ATSF 🇵🇪🇺🇸 (@rjbernardomd) 's Twitter Profile Photo

(With permission) After > 1 year of experience with #sotatercept , we are used to see these results. Yet, nothing makes me happier than when I write my report looking like this. I met this person already on 100 ng/kg/min (pre sotatercept). PAP 110/53/77, CI 1.6 The Pulmonary Hypertension Association

(With permission)
After &gt; 1 year of experience with #sotatercept , we are used to see these results. Yet, nothing makes me happier than when I write my report looking like this.

I met this person already on 100 ng/kg/min (pre sotatercept). PAP 110/53/77, CI 1.6 <a href="/PHAssociation/">The Pulmonary Hypertension Association</a>
Jose Gomez-Arroyo, M.D, Ph.D (@jgomezarroyo) 's Twitter Profile Photo

What does it really take to move science from the bench to the bedside? 🧬🚨🚨🚨 Join us at #ATS2025 for a behind-the-scenes look at the hurdles, pivots, and breakthroughs that shape translational research. Don’t miss the stories behind the science. ats2025.d365.events/directory/sess…

ATS PC Assembly (@ats_pc) 's Twitter Profile Photo

Good Morning and welcome to another awesome day at #ATS2025! Today is jam-packed with 🔥#PVD #PH #RV #PulmCirc sessions, so put those 👟on & get excited for all these great presentations 🎉 And don’t miss our ATS PC Assembly meeting TODAY at 5p! Today’s sessions ⬇️

Good Morning and welcome to another awesome day at #ATS2025!  Today is jam-packed with 🔥#PVD #PH #RV #PulmCirc sessions, so put  those 👟on &amp; get excited for all these great presentations 🎉 And don’t miss our <a href="/ATS_PC/">ATS PC Assembly</a> meeting TODAY at 5p! Today’s sessions ⬇️
ATS_Assemblies (@ats_assemblies) 's Twitter Profile Photo

Today! First webinar post #ATS2925 -- June 3rd 12pm ET on "3D Imaging Reveals Complex Microvascular Remodeling in the Right Ventricle in Pulmonary Hypertension" Join us for this exciting Journal Club! Register here: shorturl.at/Ewz9W